Frankfurt - Delayed Quote EUR
Innate Pharma S.A. (IDD.F)
1.7460
+0.0100
+(0.58%)
At close: April 25 at 8:04:30 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 5 | 4 |
| Avg. Estimate | -- | -- | 92.06M | 128.31M |
| Low Estimate | -- | -- | 12.94M | 6.75M |
| High Estimate | -- | -- | 184M | 288M |
| Year Ago Sales | -- | -- | 20.12M | 92.06M |
| Sales Growth (year/est) | -- | -- | 357.55% | 39.37% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IDD.F | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Related Tickers
HYL.BR Hyloris Pharmaceuticals SA
6.30
-0.74%
ADAG Adagene Inc.
1.4200
+4.41%
ONWD.BR Onward Medical N.V.
4.0150
-0.12%
ITOS iTeos Therapeutics, Inc.
7.35
-1.47%
NUVL Nuvalent, Inc.
73.48
-0.68%
KYMR Kymera Therapeutics, Inc.
33.26
-0.89%
RLAY Relay Therapeutics, Inc.
3.2000
+0.31%
SGMO Sangamo Therapeutics, Inc.
0.7870
-3.42%
SWTX SpringWorks Therapeutics, Inc.
44.72
-0.47%
BHVN Biohaven Ltd.
19.84
-15.21%